CervoMed Inc. (CRVO) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $41 million, CervoMed Inc. is a micro-cap company. The stock currently trades at $4.15, up 6.68% today, with a 52-week range of $1.92–$16.94.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | $-2.02 | -146.3% | |
| 2023 | — | $-0.82 | -100.0% | |
| 2022 | $2038891.00 | $-7.65 | -97.9% | |
| 2021 | $97626748.00 | $-0.25 | +81.4% | |
| 2020 | $53831973.00 | $-0.30 | +702.7% | |
| 2019 | $6706509.00 | $-1.76 | +81687176.7% | |
| 2018 | $-8.21 | $-8.21 | -323.2% | |
| 2017 | $-1.94 | $-0.21 | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-17 | 0001437749-25-007829 | SEC ↗ |
| 2023-12-31 | 2024-03-29 | 0001437749-24-010064 | SEC ↗ |
| 2022-12-31 | 2023-03-24 | 0001437749-23-007795 | SEC ↗ |
| 2021-12-31 | 2022-03-18 | 0001437749-22-006737 | SEC ↗ |
| 2020-12-31 | 2021-03-17 | 0001437749-21-006236 | SEC ↗ |
| 2019-12-31 | 2020-03-17 | 0001437749-20-005469 | SEC ↗ |
| 2018-12-31 | 2019-03-19 | 0001437749-19-005256 | SEC ↗ |
| 2017-12-31 | 2018-04-02 | 0001437749-18-006050 | SEC ↗ |
| 2016-12-31 | 2017-03-31 | 0001437749-17-005713 | SEC ↗ |
| 2015-12-31 | 2016-03-25 | 0001437749-16-028395 | SEC ↗ |
| 2014-12-31 | 2015-04-03 | 0001104659-15-025785 | SEC ↗ |
| 2013-12-31 | 2014-04-15 | 0001019687-14-001441 | SEC ↗ |
| 2012-12-31 | 2013-04-16 | 0001019687-13-001395 | SEC ↗ |
| 2011-12-31 | 2012-05-21 | 0001019687-12-001932 | SEC ↗ |
| 2010-12-31 | 2011-04-26 | 0001157523-11-002225 | SEC ↗ |
| 2009-12-31 | 2010-04-15 | 0001157523-10-002063 | SEC ↗ |
| 2008-12-31 | 2009-04-15 | 0001144204-09-020840 | SEC ↗ |